<table id="_Ref427829890" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6: Effects of Other Drugs/Substances on ASTAGRAF XL<sup>a</sup>
</caption>
<col width="36%"></col>
<col width="35%"></col>
<col width="30%"></col>
<tfoot>
<tr>
<td align="left" colspan="3" stylecode="Botrule" valign="top">
<sup>a</sup>   ASTAGRAF XL dosage adjustment recommendation based on observed effect of coadministered drug on tacrolimus exposures <content stylecode="italics">[see <linkhtml href="#ID_f47472e5-cac1-40e2-9b5e-68d77961ca1b">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_74610c82-2f5a-499d-9893-2af6ae98e6a3">12.3</linkhtml>)]</content>, literature reports of altered tacrolimus exposures, or the other drug’s known CYP3A inhibitor/inducer status<br/>
<sup>b</sup>   High dose or double strength grapefruit juice is a <content stylecode="italics">strong</content> CYP3A inhibitor; low dose or single strength grapefruit juice is a <content stylecode="italics">moderate</content> CYP3A inhibitor<br/>
<sup>c</sup>   Strong CYP3A inhibitor/inducer, based on reported effect on exposures to tacrolimus along with supporting <content stylecode="italics">in vitro</content> CYP3A inhibitor/inducer data, or based on drug-drug interaction studies with midazolam (sensitive CYP3A probe substrate)</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Drug/Substance Class or Name</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Drug Interaction Effect</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Recommendations</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Grapefruit or grapefruit juice<sup>b</sup>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_4af91235-b816-4fdc-aa61-d4e53e6ae297">5.7</linkhtml>, <linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>, <linkhtml href="#ID_dbb80d4d-8bb7-43a4-9be3-1365b4798364">5.11</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Avoid grapefruit or grapefruit juice</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Alcohol</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May increase the rate of tacrolimus release and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation ) <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_4af91235-b816-4fdc-aa61-d4e53e6ae297">5.7</linkhtml>, <linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>, <linkhtml href="#ID_dbb80d4d-8bb7-43a4-9be3-1365b4798364">5.11</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Avoid alcoholic beverages</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Strong CYP3A Inducers<sup>c</sup>:</paragraph>
<paragraph>    Antimycobacterials (e.g., rifampin, rifabutin), anticonvulsants (e.g., phenytoin, carbamazepine and phenobarbital), St John’s Wort</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May decrease tacrolimus whole blood trough concentrations and increase the risk of rejection <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Increase ASTAGRAF XL dose and monitor tacrolimus whole blood trough concentrations <content stylecode="italics">[see <linkhtml href="#ID_64001129-9a79-4b2c-84a1-0d80b88a84c9">Dosage and Administration</linkhtml> (<linkhtml href="#ID_0cbf6328-5796-4a14-9842-cb38cc2d07aa">2.3</linkhtml>, <linkhtml href="#ID_6eb2c7c9-2303-4da6-96dd-211e4b119cf1">2.4</linkhtml>) and <linkhtml href="#ID_f47472e5-cac1-40e2-9b5e-68d77961ca1b">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_74610c82-2f5a-499d-9893-2af6ae98e6a3">12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Strong CYP3A Inhibitors<sup>c</sup>:</paragraph>
<paragraph>    Protease inhibitors (e.g, nelfinavir, telaprevir, boceprevir, ritonavir), azole antifungals (e.g., voriconazole, posaconazole, itraconazole, ketoconazole), antibiotics (e.g., clarithromycin, troleandomycin, chloramphenicol), nefazodone, schisandra sphenanthera extracts</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_4af91235-b816-4fdc-aa61-d4e53e6ae297">5.7</linkhtml>, <linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>, <linkhtml href="#ID_dbb80d4d-8bb7-43a4-9be3-1365b4798364">5.11</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Reduce ASTAGRAF XL dose (for voriconazole and posaconazole, give one-third of the original dose) and adjust dose based on tacrolimus whole blood trough concentrations <content stylecode="italics">[see <linkhtml href="#ID_64001129-9a79-4b2c-84a1-0d80b88a84c9">Dosage and Administration</linkhtml> (<linkhtml href="#ID_0cbf6328-5796-4a14-9842-cb38cc2d07aa">2.3</linkhtml>, <linkhtml href="#ID_6eb2c7c9-2303-4da6-96dd-211e4b119cf1">2.4</linkhtml>) and <linkhtml href="#ID_f47472e5-cac1-40e2-9b5e-68d77961ca1b">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_74610c82-2f5a-499d-9893-2af6ae98e6a3">12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Mild or Moderate CYP3A Inhibitors:</paragraph>
<paragraph>    Clotrimazole, antibiotics (e.g., erythromycin, fluconazole), calcium channel blockers (e.g., verapamil, diltiazem, nifedipine, nicardipine), amiodarone, danazol, ethinyl estradiol, cimetidine, lansoprazole and omeprazole</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_4af91235-b816-4fdc-aa61-d4e53e6ae297">5.7</linkhtml>, <linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>, <linkhtml href="#ID_dbb80d4d-8bb7-43a4-9be3-1365b4798364">5.11</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Monitor tacrolimus whole blood trough concentrations and reduce ASTAGRAF XL dose if needed <content stylecode="italics">[see <linkhtml href="#ID_64001129-9a79-4b2c-84a1-0d80b88a84c9">Dosage and Administration</linkhtml> (<linkhtml href="#ID_0cbf6328-5796-4a14-9842-cb38cc2d07aa">2.3</linkhtml>, <linkhtml href="#ID_6eb2c7c9-2303-4da6-96dd-211e4b119cf1">2.4</linkhtml>) and <linkhtml href="#ID_f47472e5-cac1-40e2-9b5e-68d77961ca1b">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_74610c82-2f5a-499d-9893-2af6ae98e6a3">12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Other drugs, such as:</paragraph>
<paragraph>    Magnesium and aluminum hydroxide antacids<br/>
<br/>    Metoclopramide</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) <content stylecode="italics">[see <linkhtml href="#ID_81c5aae7-9129-4a89-9194-fbd08fe45806">Warnings and Precautions</linkhtml> (<linkhtml href="#ID_4af91235-b816-4fdc-aa61-d4e53e6ae297">5.7</linkhtml>, <linkhtml href="#ID_9de5dcf0-6b22-4716-8ef3-f4b3b8e7a715">5.10</linkhtml>, <linkhtml href="#ID_dbb80d4d-8bb7-43a4-9be3-1365b4798364">5.11</linkhtml>)]</content>
</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>Monitor tacrolimus whole blood trough concentrations and reduce ASTAGRAF XL dose if needed <content stylecode="italics">[see <linkhtml href="#ID_64001129-9a79-4b2c-84a1-0d80b88a84c9">Dosage and Administration</linkhtml> (<linkhtml href="#ID_0cbf6328-5796-4a14-9842-cb38cc2d07aa">2.3</linkhtml>, <linkhtml href="#ID_6eb2c7c9-2303-4da6-96dd-211e4b119cf1">2.4</linkhtml>) and <linkhtml href="#ID_f47472e5-cac1-40e2-9b5e-68d77961ca1b">Clinical Pharmacology</linkhtml> (<linkhtml href="#ID_74610c82-2f5a-499d-9893-2af6ae98e6a3">12.3</linkhtml>)]</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Mild or Moderate CYP3A Inducers</paragraph>
<paragraph>    Methylprednisolone, prednisone</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>May decrease tacrolimus concentrations</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Monitor tacrolimus whole blood trough concentrations and adjust ASTAGRAF XL dose if needed <content stylecode="italics">[see <linkhtml href="#ID_64001129-9a79-4b2c-84a1-0d80b88a84c9">Dosage and Administration</linkhtml> (<linkhtml href="#ID_0cbf6328-5796-4a14-9842-cb38cc2d07aa">2.3</linkhtml>, <linkhtml href="#ID_6eb2c7c9-2303-4da6-96dd-211e4b119cf1">2.4</linkhtml>)]</content>
</paragraph>
</td>
</tr>
</tbody>
</table>